Lupin Limited has informed the Exchange regarding a press release dated April 17, 2025, titled "Lupin Receives EIR from US FDA for its Injectable Facility in Nagpur".
Lupin Limited has informed the Exchange regarding a press release dated April 17, 2025, titled "Lupin Receives EIR from US FDA for its Injectable Facility in Nagpur".